SOPHiA GENETICS SA
SOPH Healthcare Health Information Services
SOPHiA GENETICS SA’s revenue for fiscal 2025 (year ended December 2025) was $77.3 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue grew 27.2%, EPS grew 9.88%, free cash flow grew 6.50% and total debt rose 1.12%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow SOPH
SOPHiA GENETICS SA (SOPH) Altman Z-score
SOPHiA GENETICS SA's Altman Z-score for fiscal 2025 is −3.43, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | −3.43 | (1.10) |
| FY2024 | −2.33 | (2.87) |
| FY2023 | 0.54 | 0.60 |
| FY2022 | −0.06 | (9.93) |
| FY2021 | 9.87 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.30 | — | 0.36 | |
| Retained earnings / total assets | (3.19) | — | −4.46 | |
| EBIT / total assets | (0.43) | — | −1.44 | |
| Market value of equity / total liabilities | 2.72 | — | 1.63 | |
| Sales / total assets | 0.47 | — | 0.47 | |
| Altman Z-score | Distress zone | −3.43 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −10.93 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| HSTM HealthStream, Inc. compare | 3.5× |
| NRC National Research Corporation compare | 3.3× |
| CARL Carlsmed, Inc. compare | 2.9× |
| MDRX Veradigm Inc. compare | 1.6× |
| WEAV Weave Communications, Inc. compare | 1.4× |
| PHR Phreesia, Inc. compare | 0.7× |
| CTEV Claritev Corporation compare | −0.4× |
| EVH Evolent Health, Inc compare | −0.4× |
| SOPH SOPHiA GENETICS SA | −3.4× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets